SCHEMBL3979355

SCHEMBL3979355

CCOC(=O)c1occc1-c1cccc(OCC(=O)c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
ALDH1A1 P00352 3/20 0.45
TSHR P16473 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
LMNA P02545 4/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
MAPK1 P28482 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
HTT P42858 1/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
POLB P06746 1/20 0.43
KDM4E B2RXH2 2/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3977084 0.84 ALDH1A1 (0.52) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3974986 0.82 PTGER4 (0.44) L3MBTL1MAPK1TDP1POLB
SCHEMBL3978230 0.81 PTGS2 (0.40) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL3982536 0.80 TSHR (0.47) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3981898 0.79 PTGER4 (0.42) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3978291 0.78 HPGD (0.39) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3975993 0.77 RAB9A (0.54) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3979529 0.77 JAK2 (0.44) MAPTSMN1; SMN2ALDH1A1L3MBTL1KDM4E
SCHEMBL3977097 0.77 FNTA (0.46) MAPTMEN1KMT2AALDH1A1TSHR
SCHEMBL3976847 0.76 SMN1; SMN2 (0.53) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 MAPT 4833/4885MEN1 1481/4885KMT2A 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.